Presse
NRW-Wirtschaftsministerin Mona Neubaur besucht Start-up betaSENSE
NRW-Wirtschaftsministerin Mona Neubaur besucht Start-up betaSENSE
NRW-Wirtschaftsministerin Mona Neubaur besucht Start-up betaSENSE
▶
Innovationspreis 2023 NRW
Spin-Off betaSENSE zieht ins BioMedizinZentrum
Spin-Off betaSENSE zieht ins BioMedizinZentrum
Oberbürgermeister Thomas Eiskirch übergab die Schlüssel feierlich an Geschäftsführer Klaus Gerwert.
▶
Publikationen
EMBO Molecuar Medicine, 2025
EMBO Molecuar Medicine, 2025
Alpha-synuclein misfolding as fluid biomarker for Parkinson’s disease measured with the iRS platform
▶
Alzheimer’s & Dementia, 2022
Alzheimer’s & Dementia, 2022
Amyloid-beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years
▶
Annals of Clinical & Translational Neurology, 2021
Annals of Clinical & Translational Neurology, 2021
TDP-43 as structure-based biomarker in amyotrophic lateral sclerosis
▶
